ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to tame blood disorders when other treatments fail
Disease control Recruiting nowThis early study tests a new drug called OM336 in adults with autoimmune cytopenias—conditions where the immune system attacks blood cells. The goal is to check safety and how the body processes the drug. About 32 people whose disease has not responded to at least one prior treat…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
New drug hopes to raise platelet counts in teens with chronic bleeding disorder
Disease control Recruiting nowThis study tests an IV drug called efgartigimod in teens aged 12 to 18 who have had immune thrombocytopenia (ITP) for over a year. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to find the right dose and see if it safely raises platelet levels. Par…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 05:07 UTC